Show simple item record

dc.contributor.authorAsamblea Mundial de la Salud, 39
dc.date.accessioned2015-12-04T17:19:16Z
dc.date.available2015-12-04T17:19:16Z
dc.date.issued1986
dc.identifier.govdocA39/13
dc.identifier.urihttp://www.who.int/iris/handle/10665/200414
dc.description(‎Punto 25 del orden del día provisional)‎en_US
dc.language.isoesen_US
dc.publisherOrganización Mundial de la Saluden_US
dc.subjectPharmaceutical productsen_US
dc.subject.meshPharmaceutical Preparationsen_US
dc.subject.meshDrug Delivery Systemsen_US
dc.subject.meshDrug Industryen_US
dc.subject.meshDrugs, Essentialen_US
dc.titleEstrategia revisada de la OMS en materia de medicamentos: informe del Director Generalen_US
dc.typeGoverning body documentsen_US
dc.subject.meshqualifierprevention and controlen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record